| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4529 | 10028-22-5 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Nephroangiosclerosis | 102.27 | 97.66 | 10 | 46 | 156 | 63488810 |
None
None
None
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:35223 | catalyst |
| CHEBI has role | CHEBI:74783 | adstringent |
None
None
None
None
None
None
None
| ID | Source |
|---|---|
| D08922 | KEGG_DRUG |
| 4019109 | VUID |
| N0000147365 | NUI |
| 4019109 | VANDF |
| CHEBI:53438 | CHEBI |
| CHEMBL5095046 | ChEMBL_ID |
| C024823 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11171 | DRUGBANK_ID |
| 3HWS7HF5XD | UNII |
| 24913 | RXNORM |
| 006096 | NDDF |
| C0060246 | UMLSCUI |
| 24826 | PUBCHEM_CID |
| 142906-29-4 | SECONDARY_CAS_RN |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| STASIS | HUMAN OTC DRUG LABEL | 1 | 10129-031 | SOLUTION | 3150 mg | DENTAL | unapproved drug other | 13 sections |
| STASIS | HUMAN OTC DRUG LABEL | 1 | 10129-031 | SOLUTION | 3150 mg | DENTAL | unapproved drug other | 13 sections |